下载
InVivoMAb Anti-SARS-CoV-2 RBD (JN.1 variant) Neutralizing Antibody (Iv0221)
Overview
Catalog No. VK565110
Brand abinScience
Host species Human
Species reactivity Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Form Liquid
Storage buffer 0.01M PBS pH 7.4
Purity >95% as determined by SDS-PAGE.
Clonality Monoclonal
Isotype IgG1, kappa
Applications ELISA, Neutralization
Target Spike glycoprotein, S glycoprotein, Spike protein S1, Receptor-Binding Domain, RBD, JN.1, SARS-CoV-2 (2019-nCoV)
Purification Protein A/G purified from cell culture supernatant.
Endotoxin level Please contact with the lab for this information.
Accession P0DTC2
Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Clone IDIv0221
Note For research use only. Not suitable for clinical or therapeutic use.
Images


SDS-PAGE
SDS-PAGE for InVivoMAb Anti-SARS-CoV-2 RBD (JN.1) Neutralizing Antibody (Iv0221).

Bioactivity
Detects SARS-CoV-2 RBD(JN.1) in indirect ELISAs.

Bioactivity
Detects Recombinant SARS-CoV-2 RBD (JN.1) Protein, C-His (Cat No.: VK565421) in indirect ELISA.